Chiellini Juventus match worn shirt, Genoa-Juventus A 2014/2015 - signed

关闭

Ended:Friday 03 April EDT 2015 于 17:01

Winner: calopantani

€494($537 USD)

慈善百分比

85%

错过了？

另一个独特的物品可能就在您身边！

联系我们

慈善百分比

85%

奖品

Giorgio Chiellini's match worn Juventus shirt!

This auction is for the Juventus shirt worn and signed by the defender for the Genoa-Juventus game in the Serie A 2014/2014 season, played on 29 October!

Features:
- Worn white and black shirt with short sleeves
- Signed by the player on the back
- Name and number applied in thin plastic
- Juventus and Scudetto crest on chest
- Official Serie A patch on the right sleeve
- #3

Giorgio Chiellini has decided to auction this item to support Telethon.

By winning this item you will support a fantastic cause!

Check out our shop and choose the best way to display your memorabilia. Click here.

Conditions: The winner will be notified via email and will receive the item within 10 working days of the auction closing. Need more information? Email [email protected] or ring us on 0203 301 5800.

Live a Dream, Make a Change

通过拍卖方式购买独特的物品前还需要买家的仔细评估。我们邀请您在购买之前查看您所掌握的所有信息和资料，包括我们的退货政策。

原因

Fondazione Telethon is a third-sector organization that has been working since 1990 to advance scientific research toward curing rare genetic diseases. It does this by supporting and implementing the best possible research: from basic research, which is necessary to understand disease mechanisms and identify new therapies, to clinical research, which involves patients. It is a great collective endeavor that feeds on the support of civil society and supporters and has repeatedly generated concrete impacts on patients' lives.

For the Telethon Foundation's mission to be fully accomplished, however, scientific results, however positive, are not enough: the therapies developed must actually be available to patients. Instead, access to treatment is increasingly compromised, particularly for advanced therapies such as gene therapies. In the face of inevitable abandonment of the field by the pharmaceutical industry, there is a risk that patients will no longer have access to life-saving therapies.

This is what happened in 2022 with the two gene therapies developed by the San Raffaele Telethon Institute for Gene Therapy in Milan for two severe congenital immunodeficiencies-Ada-Scid and Wiskott-Aldrich syndrome. Children with these diseases have been and are at risk of not being able to benefit from these therapies-an unacceptable situation for the Telethon Foundation, which decided to correct it by taking responsibility for producing and distributing them. A commitment compl

网站